Top Ten most popular articles on this week

pharmafile | August 24, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10 

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile Chinese manufacturer Sichuan Friendly Pharmaceutical failed an FDA inspection thus prompting a recall in America.  

Meanwhile a Bristol University PhD student hit the jackpot after his small biotech was bought for £620 million by Novo Nordisk. In contrast Indian biotech owner Nitin Sandesara was detained in Dubai over £550 million fraud allegations.

For all the latest pharmaceutical news and updates, check out this week’s ten most popular articles on now!

10. “Triple pill” blood pressure combo proves more effective, safe than standard care

A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating high blood pressure than any of its constituent elements alone, according to research conducted by the George Institute for Global Health.

9. Blockchain deployed in fight against fake pharmaceuticals in India

Indian policymakers in collaboration with an Indian hospital chain and a an American multinational, have initiated plans to deploy blockchain technology in the fight against counterfeit pharmaceutical drugs. 

8. $3 million GSK verdict thrown out of court

A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK could not be sued over the suicide of an attorney who took a generic version of GSK’s antidepressant medication Paxil.

7. Leaked letter warns of NHS disruption after Brexit

NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is unprepared for Brexit in a letter leaked to The Times newspaper.

6. AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD

AZ’s Bevespi Aerosphere inhaler posted disappointing results compared to a rival product, GSK’s Anoro, in the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD).

5. Indian biotech owner detained in Dubai over £550m fraud allegations

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech has been detained in Dubai in relation to INR 50 billion (£550 million) fraud allegations.

4. Thyroid medication recalled after Chinese supplier fails inspection

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly Pharmaceutical Co failed an FDA inspection.

3. GSK announces closure of Sligo, Ireland facilities

British multinational GlaxoSmithKline has announced the closure of its manufacturing facilities in Sligo, Ireland.

2. Novo Nordisk buys Bristol University biotech in £620m deal

Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth more than £620 million.

1. Genentech to axe 223 staff from San Francisco HQ

Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 August and running on into November.

Related Content

Travellers with Indian-made AZ jab may face European ban

Up to 5 million Britons planning to travel to Europe may face a travel ban …

India report record number of COVID deaths as bodies drift down Ganges

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 …

Pharmafile's top 10 news roundup’s top 10 news stories of the week

Among our ten most-read stories this week: NICE has announced that more patients are eligible …

Latest content